Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription

Articles published in
Clin Cardiol
    June 2023
  1. HUANG H, Leung KSK, Garg T, Mazzoleni A, et al
    Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.
    Clin Cardiol. 2023 Jun 1. doi: 10.1002/clc.24059.
    >> Share

    May 2023
  2. ROMANO S, Minardi S, Patrizi G, Palama Z, et al
    Sport in ischemic heart disease: Focus on primary and secondary prevention.
    Clin Cardiol. 2023 May 28. doi: 10.1002/clc.24052.
    >> Share

  3. MU X, Qiu M, Li Y, Li Z, et al
    N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA(2) DS(2) -VASc risk score for long-term cardiovascular events in acute coronary syndrome patients with atrial fibrillation.
    Clin Cardiol. 2023 May 22. doi: 10.1002/clc.24037.
    >> Share

  4. GONG X, Hua R, Bai J, Wu T, et al
    Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.
    Clin Cardiol. 2023 May 16. doi: 10.1002/clc.24025.
    >> Share

  5. CHEN T, Liu Y, Zhang J, Sun Z, et al
    Percutaneous closure of ventricular septal rupture after myocardial infarction: A retrospective study of 81 cases.
    Clin Cardiol. 2023 May 15. doi: 10.1002/clc.24027.
    >> Share

    April 2023
  6. LIU R, Liu H, Yuan D, Chen Y, et al
    For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort study.
    Clin Cardiol. 2023 Apr 28. doi: 10.1002/clc.24021.
    >> Share

  7. WANG H, Li L, Ma Y
    Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24002.
    >> Share

  8. WANG B, Liu X, Hao W, Fan J, et al
    Comorbid obstructive sleep apnea is associated with adverse cardiovascular outcomes in female patients with acute coronary syndrome complicating metabolic syndrome.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24020.
    >> Share

  9. WANG Y, Sun J, Sun K, Li L, et al
    ECG-based cardiodynamicsgram can reflect anomalous functional information in coronary artery disease.
    Clin Cardiol. 2023 Apr 6. doi: 10.1002/clc.24019.
    >> Share

  10. VERVAAT FE, van der Gaag A, Smetsers C, Barneveld PC, et al
    Design and rationale of the efficacy of spinal cord stimulation in patients with refractory angina pectoris (SCRAP) trial.
    Clin Cardiol. 2023 Apr 4. doi: 10.1002/clc.24016.
    >> Share

  11. CATAPANO AL, De Caterina R, Jukema JW, Klempfner R, et al
    Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative.
    Clin Cardiol. 2023;46:407-415.
    >> Share

    March 2023
  12. KHALAJI A, Ajam A, Sheikhy A, Behnoush AH, et al
    Mortality across the spectrum of hemoglobin level in patients undergoing surgical coronary revascularization.
    Clin Cardiol. 2023 Mar 23. doi: 10.1002/clc.24004.
    >> Share

  13. ZHANG C, Zeng S, Ji W, Li Z, et al
    Synergistic role of circulating CD14++CD16+ monocytes and fibrinogen in predicting the cardiovascular events after myocardial infarction.
    Clin Cardiol. 2023 Mar 22. doi: 10.1002/clc.24005.
    >> Share

  14. YI C, Junyi G, Fengju L, Qing Z, et al
    Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients.
    Clin Cardiol. 2023 Mar 10. doi: 10.1002/clc.24003.
    >> Share

  15. WADA S, Iwanaga Y, Nakai M, Nakao YM, et al
    Combination of coronary CT angiography, FFR(CT) , and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD.
    Clin Cardiol. 2023 Mar 1. doi: 10.1002/clc.23989.
    >> Share

  16. WANG B, Gao Y, Zhao Y, Xu C, et al
    The spectrum of angiography-derived IMR according to morphological and physiological coronary stenosis in patients with suspected myocardial ischemia.
    Clin Cardiol. 2023 Mar 1. doi: 10.1002/clc.23999.
    >> Share

    February 2023
  17. KIM Y, Choi AD, Telluri A, Lipkin I, et al
    Atherosclerosis Imaging Quantitative Computed Tomography (AI-QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial.
    Clin Cardiol. 2023 Feb 27. doi: 10.1002/clc.23995.
    >> Share

  18. DEAN YE, Shebl MA, Rouzan SS, Bamousa BAA, et al
    Association between insomnia and the incidence of myocardial infarction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Feb 25. doi: 10.1002/clc.23984.
    >> Share

  19. LIU ES, Yang TH, Tai TH, Chiang CH, et al
    Long-term outcomes after stent implantation in very small vessel coronary artery disease.
    Clin Cardiol. 2023 Feb 23. doi: 10.1002/clc.24000.
    >> Share

  20. YOUN YJ, Jeon HS, Kim YI, Lee JH, et al
    Impact of the ultra-long 48 mm drug-eluting stent on procedural and clinical outcomes in patients with diffuse long coronary artery disease.
    Clin Cardiol. 2023 Feb 20. doi: 10.1002/clc.23997.
    >> Share

  21. CHEN W, Lin G, Dai C, Xu K, et al
    Predictive value of serum iron on heart failure in patients with acute ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Feb 13. doi: 10.1002/clc.23990.
    >> Share

  22. DESAI R, Fadah K, Srikanth S, Neha NFN, et al
    Fibrinogen-albumin ratio predicting major adverse cardiovascular outcomes post-percutaneous coronary intervention: A systematic review and exploratory meta-analysis.
    Clin Cardiol. 2023 Feb 1. doi: 10.1002/clc.23981.
    >> Share

  23. JUSTO FA, de Deus Herrera B, Soares PR, Scudeler TL, et al
    Plato's allegory of the cave and the paradigm of complete revascularization in STEMI.
    Clin Cardiol. 2023;46:232-233.
    >> Share

    January 2023
  24. PARK HB, Lee J, Hong Y, Byungchang S, et al
    Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23964.
    >> Share

  25. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23972.
    >> Share

  26. KODESH A, Bental T, Vaknin-Assa H, Talmor-Barkan Y, et al
    The independent impact of dementia in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    Clin Cardiol. 2023 Jan 12. doi: 10.1002/clc.23967.
    >> Share

  27. BEHNOUSH AH, Khalaji A, Rezaee M, Momtahen S, et al
    Machine learning-based prediction of 1-year mortality in hypertensive patients undergoing coronary revascularization surgery.
    Clin Cardiol. 2023 Jan 1. doi: 10.1002/clc.23963.
    >> Share

  28. AL-KASSOU B, Veulemans V, Shamekhi J, Maier O, et al
    Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience.
    Clin Cardiol. 2023;46:67-75.
    >> Share

    December 2022
  29. MOHAMMED AA, Zhang H, Abdu FA, Liu L, et al
    Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Clin Cardiol. 2022 Dec 25. doi: 10.1002/clc.23962.
    >> Share

  30. LIN L, Huang J, Liu Z, Chen P, et al
    Associations of siesta and total sleep duration with hypertension or cardiovascular diseases in middle-aged and older adults.
    Clin Cardiol. 2022 Dec 12. doi: 10.1002/clc.23954.
    >> Share

  31. LUO F, Luo JY, Liu F, Qiu YJ, et al
    Coronary artery calcium and cystatin C for risk stratification of MACCEs and all-cause death in symptomatic patients.
    Clin Cardiol. 2022 Dec 9. doi: 10.1002/clc.23959.
    >> Share

  32. LI R, Shen L, Ma W, Yan B, et al
    Use of machine learning models to predict in-hospital mortality in patients with acute coronary syndrome.
    Clin Cardiol. 2022 Dec 7. doi: 10.1002/clc.23957.
    >> Share

  33. BONACA MP, Szarek M, Debus ES, Nehler MR, et al
    Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
    Clin Cardiol. 2022;45:1143-1146.
    >> Share

  34. SAADA M, Kobo O, Polad J, Halabi M, et al
    Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Clin Cardiol. 2022;45:1211-1219.
    >> Share

    November 2022
  35. BROCKMEYER M, Wies E, Joerges J, Sommer J, et al
    Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2022 Nov 30. doi: 10.1002/clc.23948.
    >> Share

  36. LIMPIJANKIT T, Jongjirasiri S, Meemook K, Unwanatham N, et al
    Predictive values of coronary artery calcium and arterial stiffness for long-term cardiovascular events in patients with stable coronary artery disease.
    Clin Cardiol. 2022 Nov 29. doi: 10.1002/clc.23955.
    >> Share

  37. GAO Y, Guo Y, Dong J, Liu Y, et al
    Differences in the prevalence of cardiovascular and metabolic diseases coinciding with clinical subtypes of obstructive sleep apnea.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23941.
    >> Share

  38. BAGAI A, Ali FM, Gregson J, Alexander KP, et al
    Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.
    Clin Cardiol. 2022 Nov 1. doi: 10.1002/clc.23915.
    >> Share

  39. COTTER B, Raisinghani A, DeMaria AN
    Established and emerging roles for ultrasound enhancing agents (contrast echocardiography).
    Clin Cardiol. 2022;45:1114-1122.
    >> Share

    October 2022
  40. DESAI NR, Farbaniec M, Karalis DG
    Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2022 Oct 20. doi: 10.1002/clc.23935.
    >> Share

  41. CHENG Q, Zhou D, Wang J, Nie Z, et al
    Sex-specific risk factors of carotid atherosclerosis progression in a high-risk population of cardiovascular disease.
    Clin Cardiol. 2022 Oct 13. doi: 10.1002/clc.23931.
    >> Share

  42. MORTENSEN MB, Sand NP, Busk M, Jensen JM, et al
    Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study.
    Clin Cardiol. 2022;45:986-994.
    >> Share

    September 2022
  43. YU Q, Guo D, Peng J, Wu Q, et al
    Prevalence and adverse outcomes of frailty in older patients with acute myocardial infarction after percutaneous coronary interventions: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Sep 28. doi: 10.1002/clc.23929.
    >> Share

  44. IVEY SL, Hanley HR, Taylor C, Stock E, et al
    Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
    Clin Cardiol. 2022 Sep 20. doi: 10.1002/clc.23921.
    >> Share

  45. SHAIK A, Kosiborod M, de Lemos JA, Gao Q, et al
    Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23923.
    >> Share

  46. NAZER RI, Albarrati AM
    The brain-before-heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single-institution experience.
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23913.
    >> Share

  47. CHEN C, Li X, Su Y, You Z, et al
    Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: "Real-world" evidence.
    Clin Cardiol. 2022 Sep 18. doi: 10.1002/clc.23898.
    >> Share

  48. MANIAR Y, Blumenthal RS, Alfaddagh A
    The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC.
    Clin Cardiol. 2022 Sep 10. doi: 10.1002/clc.23918.
    >> Share

  49. YI M, Cao Q, Tang WH, Liu Q, et al
    Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23899.
    >> Share

  50. YAO H, Guo Q, Cheng Y, Zhu T, et al
    Predictors and morphological properties of culprit healed plaques in patients with angina pectoris.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23896.
    >> Share

  51. VALENTINE CM, Chazal RA
    Essential nonclinical competencies for cardiovascular specialists imperatives for training.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23914.
    >> Share

  52. BRACEWELL NJ, Plasschaert J, Conti CR, Keeley EC, et al
    Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease.
    Clin Cardiol. 2022 Sep 2. doi: 10.1002/clc.23911.
    >> Share

  53. YANG Y, Hong Y, Yang W, Zheng Z, et al
    Association of lipoprotein(a) with aortic dissection.
    Clin Cardiol. 2022;45:908-912.
    >> Share

    August 2022
  54. SHARMA P, Shah K, Loomba J, Patel A, et al
    The impact of COVID-19 on clinical outcomes among acute myocardial infarction patients undergoing early invasive treatment strategy.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23908.
    >> Share

  55. MOTAWEA KR, Gaber H, Singh RB, Swed S, et al
    Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23894.
    >> Share

    July 2022
  56. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    >> Share

  57. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    >> Share

  58. ZDANYTE M, Martus P, Nestele J, Bild A, et al
    Risk assessment in COVID-19: Prognostic importance of cardiovascular parameters.
    Clin Cardiol. 2022 Jul 5. doi: 10.1002/clc.23883.
    >> Share

    June 2022
  59. WU C, Bu R, Wang Y, Xu C, et al
    Rehabilitation effects of circuit resistance training in coronary heart disease patients: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23855.
    >> Share

  60. LIMPIJANKIT T, Chandavimol M, Srimahachota S, Kanoksilp A, et al
    Dose-dependent effect of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23877.
    >> Share

  61. DE LUCA L, Calabro P, Chirillo F, Rolfo C, et al
    Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23878.
    >> Share

  62. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    >> Share

  63. WON KB, Park HB, Heo R, Lee BK, et al
    Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.
    Clin Cardiol. 2022 Jun 8. doi: 10.1002/clc.23870.
    >> Share

  64. SCOTT C, Lateef SS, Hong CG, Dey AK, et al
    Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) study.
    Clin Cardiol. 2022;45:622-628.
    >> Share

  65. MIYATA K, Asano T, Saito A, Abe K, et al
    Heart Team risk assessment with angiography-derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial.
    Clin Cardiol. 2022;45:605-613.
    >> Share

    May 2022
  66. GAO L, Wang B, Cheng R
    Reply to comment on "Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis".
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23852.
    >> Share

  67. DENG JH, Zhang JX
    Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23851.
    >> Share

  68. YOU W, Zhou Y, Wu Z, Meng P, et al
    Post-PCI quantitative flow ratio predicts 3-year outcome after rotational atherectomy in patients with heavily calcified lesions.
    Clin Cardiol. 2022;45:558-566.
    >> Share

    April 2022
  69. MOTAMED N, Ajdarkosh H, Karbalaie Niya MH, Panahi M, et al
    Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.
    Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23827.
    >> Share

    March 2022
  70. MA R, Gao J, Mao S, Wang Z, et al
    Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.
    Clin Cardiol. 2022 Mar 30. doi: 10.1002/clc.23818.
    >> Share

  71. STOHR R, Dirrichs T, Kneizeh K, Reinartz S, et al
    Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.
    Clin Cardiol. 2022 Mar 25. doi: 10.1002/clc.23819.
    >> Share

  72. SUN M, Xing Y, Guo Y, Cao X, et al
    Left atrial reservoir strain is an outstanding predictor of adverse cardiovascular outcomes in patients undergoing maintenance hemodialysis: Assessment via three-dimensional speckle tracking echocardiography.
    Clin Cardiol. 2022 Mar 21. doi: 10.1002/clc.23815.
    >> Share

  73. HOU J, Sun Y, Zhang L, Wang W, et al
    Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23811.
    >> Share

  74. TOPPILA I, Ukkola-Vuoti L, Perttila J, Tornwall O, et al
    Cardiovascular event rate and death in high-risk secondary prevention patient cohort in Finland: A registry study.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23814.
    >> Share

  75. SUN L, Zhou M, Ji Y, Wang X, et al
    Off-pump versus on-pump coronary artery bypass grafting for octogenarians: A meta-analysis involving 146 372 patients.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23794.
    >> Share

  76. LUPU L, Taha L, Banai A, Shmueli H, et al
    Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.
    Clin Cardiol. 2022 Mar 9. doi: 10.1002/clc.23781.
    >> Share

  77. STEHLI J, Dinh D, Dagan M, Dick R, et al
    Sex differences in treatment and outcomes of patients with in-hospital ST-elevation myocardial infarction.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23797.
    >> Share

  78. XUE L, Yang YC, Zhao Q, Zhao ZH, et al
    The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
    >> Share

  79. WANG G, Zhao N, Zhong S, Wang H, et al
    Association of early repolarization pattern and ventricular fibrillation in patients with vasospastic angina: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23804.
    >> Share

  80. WEN XS, Luo R, Liu J, Liu ZQ, et al
    The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
    >> Share

    February 2022
  81. LEE P, Brennan A, Dinh D, Stub D, et al
    The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data.
    Clin Cardiol. 2022 Feb 22. doi: 10.1002/clc.23798.
    >> Share

  82. KNOERY C, McEwan KA, Manktelow M, Watt J, et al
    Using latent class analysis to identify clinical features of patients with occlusive myocardial infarction: Preangiogram prediction remains difficult.
    Clin Cardiol. 2022 Feb 8. doi: 10.1002/clc.23755.
    >> Share

  83. VRSALOVIC M, Vrsalovic Presecki A, Aboyans V
    Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies.
    Clin Cardiol. 2022 Feb 7. doi: 10.1002/clc.23776.
    >> Share

  84. ZHAO Y, Zhou P, Gao W, Zhong H, et al
    Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantation.
    Clin Cardiol. 2022 Feb 4. doi: 10.1002/clc.23787.
    >> Share

    Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Clin Cardiol. 2022;45:152-161.
    >> Share

    January 2022
  86. XU J, Chen X, Xie Y, Lin J, et al
    Improvement of cardiac function after coronary artery bypass grafting surgery reduces the risk of postoperative acute kidney injury.
    Clin Cardiol. 2022 Jan 30. doi: 10.1002/clc.23785.
    >> Share

  87. LIN XL, Sun HX, Li FQ, Zhao JY, et al
    Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23749.
    >> Share

  88. SANG DS, Zhang Q, Song D, Tao J, et al
    Association between brachial-ankle pulse wave velocity and cardiovascular and cerebrovascular disease in different age groups.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23777.
    >> Share

  89. YANG L, Zhu H, Sun Y, Yan P, et al
    Value of M2BP in predicting in-stent restenosis in patients after coronary drug-eluting stent implantation.
    Clin Cardiol. 2022 Jan 15. doi: 10.1002/clc.23775.
    >> Share

  90. CHI G, Lee JJ, Kazmi SHA, Fitzgerald C, et al
    Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design.
    Clin Cardiol. 2022 Jan 12. doi: 10.1002/clc.23773.
    >> Share

  91. QIN Q, Chen L, Ge L, Qian J, et al
    A comparison of long-term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct-related artery after PCI of acute myocardial infarction.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23771.
    >> Share

  92. SHI Y, He S, Luo J, Jian W, et al
    Lesion characteristics and procedural complications of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery: A meta-analysis.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23766.
    >> Share

    December 2021
  93. ZHANG M, Zuo HJ, Yang HX, Nan N, et al
    Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction.
    Clin Cardiol. 2021 Dec 28. doi: 10.1002/clc.23770.
    >> Share

  94. DALLI PEYDRO E, Sanz Sevilla N, Tuzon Segarra MT, Miro Palau V, et al
    A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome.
    Clin Cardiol. 2021 Dec 24. doi: 10.1002/clc.23757.
    >> Share

    November 2021
  95. DISSANAYAKE HU, Colpani JT, Sutherland K, Loke W, et al
    Obstructive sleep apnea therapy for cardiovascular risk reduction-Time for a rethink?
    Clin Cardiol. 2021 Nov 17. doi: 10.1002/clc.23747.
    >> Share

  96. XING Z, Wang X, Pei J, Zhu Z, et al
    The association of interferon-alpha with development of collateral circulation after artery occlusion.
    Clin Cardiol. 2021;44:1621-1627.
    >> Share

    October 2021
  97. DIAO K, Wang D, Chen Z, Wu X, et al
    Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
    Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
    >> Share

  98. HOFER F, Kazem N, Schweitzer R, Horvat P, et al
    The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.
    Clin Cardiol. 2021 Oct 19. doi: 10.1002/clc.23741.
    >> Share

  99. GONG Y, Li X, Ma X, Yu H, et al
    Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.
    Clin Cardiol. 2021 Oct 15. doi: 10.1002/clc.23725.
    >> Share

  100. MOHAMED A
    Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
    Clin Cardiol. 2021;44:1371-1376.
    >> Share

    September 2021
  101. LIMPIJANKIT T, Vathesatogkit P, Matchariyakul D, Yingchoncharoen T, et al
    Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23735.
    >> Share

  102. CHEN G, Farris MS, Cowling T, Pinto L, et al
    Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23732.
    >> Share

    August 2021
  103. KIM YK, Jang CW, Kwon SH, Kim JH, et al
    Ten-year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion.
    Clin Cardiol. 2021;44:1161-1168.
    >> Share

    July 2021
  104. TANG J, Hou H, Chu J, Chen F, et al
    Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
    Clin Cardiol. 2021;44:978-986.
    >> Share

    May 2021
  105. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
    Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
    >> Share

    March 2021
  106. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
    Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
    >> Share

  107. KONIGSTEIN M, Ponticelli F, Zivelonghi C, Merdler I, et al
    Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Clin Cardiol. 2021;44:424-428.
    >> Share

    February 2021
  108. HUANG W, Lim LMH, Aurangzeb AS, Wong CJ, et al
    Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification.
    Clin Cardiol. 2021;44:267-275.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016